Turing Pharmaceuticals

59 articles about Turing Pharmaceuticals

• Life After Martin Shkreli — A Conversation With Turing's R&D Head

  8/24/2016

• Marina Biotech Acquires Late-Stage Program from Turing in $95 Million Deal

  5/3/2016

• Turing Provides Key Facts To Congressional Oversight Committee

  2/4/2016

• Emails Reveal Turing, Valeant Price Increases Were Basis for Revenue Growth

  2/3/2016

• Turing To Testify At Congressional Hearing On Drug Pricing

  1/25/2016

• Lesson From Turing's Martin Shkreli: Pharmas Need To Walk Before They Can Talk

  12/30/2015

• In Wake of Shkreli Arrest, Turing Eliminates Workforce and Begins CEO Search

  12/29/2015

• Turing Release: Continued Availability Of Daraprim (pyrimethamine)

  12/21/2015

• Martin Shkreli Resigns from Turing, Company Taps New CEO

  12/21/2015

• U.S. Attorney Unveils Indictment Against Turing CEO Martin Shkreli

  12/18/2015

• Notorious Turing CEO Martin Shkreli Arrested for Securities Fraud

  12/18/2015

• Report Questions Feasibility of Turing’s R&D Plan

  12/16/2015

• Turing's Martin Shkreli Says He Should Have Increased the Price of Daraprim Higher than 5,000%

  12/7/2015

• More Turing Executives Take Top Spots at Floundering KaloBios

  12/4/2015

• Shkreli's Turing Rolls Out a 50% Price Cut for Daraprim

  11/30/2015

• KaloBios Comes Alive Again After Turing Pharma's Martin Shkreli Takes Stake

  11/20/2015

• Turing Pharma Announces Research Agreement With The University Of Toledo For Canavan Disease

  11/18/2015

• Turing Pharma Initiates Dosing In Phase I Clinical Trial Of TUR-004 For Epileptic Encephalopathies

  11/16/2015

• Turing Pharma's Martin Shkrel Is Livestreaming Exactly How Lame He Is

  11/13/2015

• Turing Pharma Announces Third Quarter Business Highlights and Financial Results

  11/13/2015